A US study found a significantly higher cost of care associated with cirrhosis vs with heart failure or chronic obstructive pulmonary disease.

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

Dr Sundeep Salvi: Shardul Nautiyal, Mumbai Tuesday, March 4, 2025, 08:00 Hrs [IST] Chronic obstructive pulmonary disease (C ...

Professor David Denning evaluates timely and accurate diagnosis of Aspergillus infection and the clinical spectrum of ...

Doctors treating Pope Francis at Rome's Gemelli Hospital reported Friday evening that the Pontiff’s respiratory condition worsened after an isolated bronchospasm.A bronchospasm is a sudden ...

Find essential government resources for wildfire recovery in Los Angeles, including FEMA aid, information about rebuilding ...

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions filled through February 2025 than in Q4 2024 Over 4,600 unique prescribers wit ...

OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024More prescriptions filled through February ...

Chronic Obstructive Pulmonary disease (COPD) has been around for almost 205 years and is one of the most prevalent non-infectious diseases in our country. It is the 2nd leading cause of death and ...

The digital Healthy at Home intervention appeared to improve quality of life for patients and decreased COPD-related distress ...

Researchers at the La Jolla Institute for Immunology (LJI) have developed a specific drug "cocktail" that promises to curb severe asthma flare-ups, potentially decreasing the reliance on inhalers ...

In today’s fast-paced world, respiratory health has become a pressing concern for many. With increasing pollution, sedentary ...